Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cottrell

Showing results (131-140 of 139) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 139 results.
Cancer Research|December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung CancerValsamo Anagnostou, Patrick M Forde, James R White, et al.
Science (New York, N.Y.)|June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockadeSneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS)Tricia R Cottrell, Jeffrey S Roskes, Michael Fotheringham, et al.
Journal for Immunotherapy of Cancer|March 8, 2019
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Journal for Immunotherapy of Cancer|February 13, 2019
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Nature|October 5, 2021
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Nature|July 22, 2021
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Pageof 14

Showing results (131-140 of 139) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 139 results.
Cancer Research|December 14, 2018
Dynamics of Tumor and Immune Responses during Immune Checkpoint Blockade in Non-Small Cell Lung CancerValsamo Anagnostou, Patrick M Forde, James R White, et al.
Science (New York, N.Y.)|June 11, 2021
Analysis of multispectral imaging with the AstroPath platform informs efficacy of PD-1 blockadeSneha Berry, Nicolas A Giraldo, Benjamin F Green, et al.
Journal for Immunotherapy of Cancer|March 7, 2025
Society for Immunotherapy of Cancer (SITC) consensus statement on essential biomarkers for immunotherapy clinical protocolsTricia R Cottrell, Michael T Lotze, Alaa Ali, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Novel Predictive Spatial Biomarker in Non-Small Cell Lung Carcinoma: The Diversity of Niches Unlocking Treatment Sensitivity (DONUTS)Tricia R Cottrell, Jeffrey S Roskes, Michael Fotheringham, et al.
Journal for Immunotherapy of Cancer|March 8, 2019
Correction to: persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Journal for Immunotherapy of Cancer|February 13, 2019
Persistent mutant oncogene specific T cells in two patients benefitting from anti-PD-1Kellie N Smith, Nicolas J Llosa, Tricia R Cottrell, et al.
Nature|October 5, 2021
Author Correction: Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Nature|July 22, 2021
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancersJustina X Caushi, Jiajia Zhang, Zhicheng Ji, et al.
Journal for Immunotherapy of Cancer|December 21, 2025
Society for Immunotherapy of Cancer: Standards for Reporting of Multiplex Immunohistochemistry/Immunofluorescence Assays (STORMI)Sam Sater, Carlo B Bifulco, Jaime Rodriguez-Canales, et al.
Pageof 14